Open Access in Biomedical Research
Total Page:16
File Type:pdf, Size:1020Kb
47 Science Policy Briefing • September 2012 Open Access in Biomedical Research Contents 2 • Foreword 16 • Diverging opinions on how best to achieve 3 • Executive summary open access in biomedical research 3 • Introduction 19 • Recommendations 6 • Open access: where are we today 20 • Conclusions in biomedical research? 21 • Useful websites and abbreviations 12 • The international landscape of open access 22 • List of contributors in biomedical research 13 • The European landscape of open access in biomedical research Foreword Open access publishing has the potential to revolutionise the way in which biomedical scientists publish and access the latest results in their field. There are opportunities to accelerate the use of open access but there are also hurdles to its widespread uptake. Over the past few months, various reports and communications have been published on the topic of open access. These include the Finch Group report on 18 June 2012, the Publishing and the Ecology of European Research (PEER) final report on 19 June 2012, the European Research Council (ERC) announcement of its new open access policy on 13 July 2012, and the European Commission’s launch of a communication and recommendations to Member States ‘Towards better access to scientific information’ on 17 July 2012. On the same day, Science Europe reaffirmed its commitment to strengthening the European Research © Clover / SuperStock Area and recognised open access as a priority area in which a common policy and action plan will be developed and implemented. This intensive period shows the timeliness of Spanish Foundation for Science and Technology (FECYT), our publication. ES; the Spanish National Health Institute Carlos III (ISCIII), In recognition of the importance of open access to ES; the Wellcome Trust, UK; the Academy of Sciences, the biomedical sciences, the European Medical Research CZ; the National Institute of Health (ISS), IT; and the Councils (EMRC) of the European Science Foundation Foundation for National Scientific Computing (FCCN), PT. (ESF), at the instigation of its Core Group member Professor Other participants included open access experts from Josef Syka of the Czech Science Foundation and the the Research Information Network (RIN), the Scholarly Academy of Sciences of the Czech Republic (GAČR and Publishing and Academic Resources Coalition (SPARC) AVČR), launched an activity to investigate what, if any, steps Europe, the Association of European Research Libraries EMRC could usefully take to improve the open access (LIBER), the European Association for Cancer Research landscape in the biomedical field across Europe. EMRC (EACR) and Knowledge Exchange, as well as experts task force meetings held in September and November from several European infrastructures, including the 2011 led to the identification of a number of issues and the European Organization for Nuclear Research (CERN) and drafting of a preliminary document. These issues included the European Molecular Biology Laboratory - European the coexistence between open access and the traditional Bioinformatics Institute (EMBL-EBI). The many valuable business model of scientific publishers (including scientific inputs from participants made it clear that the current model learned societies), the recognised challenges associated for accessing biomedical research is far from ideal and that with researchers understanding the concept of open all research stakeholders (funding agencies, publishers, access and depositing their research in local repositories, research performing institutions, research libraries and the recognition of PubMed Central (PMC) as a model of learned societies) need to work together to shift to an open disciplinary repository in the biomedical field, and the access model in the field. However, a number of potential desirability and/or feasibility of expanding UK PubMed hurdles, discussed in this briefing, remain to be overcome. Central (UKPMC) to include more European biomedical Finally, we would like to thank the Science Policy Briefing research outputs. While this report was in preparation, Chair, Professor Syka, the task force, the expert group the ERC joined UKPMC and funders agreed to rename it members and the ESF-EMRC staff – all listed at the end of ‘Europe PMC’ as of November 2012. the publication – for their excellent work. An expert group meeting took place in Madrid on 21-22 March 2012 hosted by the Spanish ‘Consejo Superior de Investigaciones Científicas’ (CSIC), one of the Professor Liselotte Højgaard task force member organisations. Participants included EMRC Chair publishers (Elsevier, BioMed Central, Public Library of Science), the European Commission, nominated experts Professor Pär Omling from 12 ESF Member Organisations (including the task ESF President and Science Europe Vice-President force members) and other research performing/funding organisations, foundations or charities, including the 2 Open Access in Biomedical Research | September 2012 Executive summary Introduction This Science Policy Briefing The Internet and technological developments that aims to accelerate the adop- have arisen from it in recent years have the potential tion of open access to research to radically change science publishing and maximise articles in the biomedical sci- the impact of research in a way that was not possible ences. Open access refers to or even envisioned when publishing was a subscription- the free availability on the and paper-based process. We envisage a full open access public Internet of scholarly future – one in which all published research generated articles published in an elec- by science researchers in the European Union (EU) is tronic format, permitting any immediately available online in human and machine user to read and re-use the readable form, published under a license that allows content provided only that the Hippocratic Oath unlimited re-use while ensuring authors’ rights of attri- author is properly acknowl- “I swear […] to give a share of bution, and with secure automatic archiving in publicly precepts and oral instruction edged and cited. We consider and all the other learning to my run databases. open access to be crucial for sons and to the sons of him The concept is not new: the 2002 Budapest Open who has instructed me” the free flow of information Access Initiative1 and the Bethesda Statement on Open between researchers and within society as a whole, and Access Publishing2, which was agreed on in 2003 by the digital revolution of recent years provides an oppor- the biomedical research community, discussed how to tunity that has not yet been fully realised to transform provide open access to primary scientific literature as access to scholarly publications. To achieve this goal this rapidly as possible. The Berlin Declaration on Open briefing makes a number of recommendations: Access to Knowledge in the Sciences and Humanities 1. There is a moral imperative for open access: research was also published in 20033. A definition is provided papers should be made freely available to all to read, in Box 1. use and re-use, with appropriate acknowledge- A successful model for the future will maximise the ment, in order to maximise the value of biomedical value of research investments by: research, build on the body of knowledge, accelerate • increasing access to the results of research undertaken the process of discovery and improve human health. in Europe, preferably so that everyone in the world has 2. Individual agencies must work together to raise free access at the point of use to all the published out- awareness of the moral imperative for open access: puts of research; agencies and organisations that fund and perform • increasing access in Europe to the global outputs of research, libraries, publishers and researchers must research; work in concert to raise awareness of the moral • ensuring that the published outputs of research are imperative for open access publishing. National, subject to effective quality assurance through peer European and international partnerships are the review; basis for the successful achievement of open access • ensuring that the scholarly communication system to research outputs. Specific actions that different develops in a sustainable way and operates cost-effec- agencies need to undertake in order to move towards tively; and this goal are outlined in this briefing. • ensuring the long-term preservation of the records of 3. All research stakeholders should work together to science. support the extension of Europe PubMed Central into a Europe-wide PubMed Central: in order to The objective of this ESF-EMRC Science Policy Briefing facilitate discoveries and innovation in biomedical is to accelerate the adoption of open access in order to research, research stakeholders should collaborate to guarantee equitable access to European biomedical establish a Europe-wide repository in biomedicine as research outputs worldwide. In this document, the term a partner site to the US equivalent PubMed Central. ‘research outputs’ refers to research publications (journal The recently rebranded Europe PubMed Central articles and conference papers4), mostly generated from represents a valuable means to achieving this goal, provided that the diversity of European partner man- 1. www.soros.org/openaccess/read 2. www.earlham.edu/~peters/fos/bethesda.htm dates and policies can be integrated. 3. http://oa.mpg.de/lang/en-uk/berlin-prozess/berliner-erklarung/ 4. Research Information Network (RIN), Publishing Research Open